SLC35B2

Chr 6

solute carrier family 35 member B2

Also known as: HLD26, PAPST1, SLL, UGTrel4

Sulfotransferases (e.g., SULT4A1; MIM 608359) use an activated form of sulfate, 3-prime-phosphoadenosine 5-prime-phosphosulfate (PAPS), as a common sulfate donor for sulfation of glycoproteins, proteoglycans, and glycolipids in the endoplasmic reticulum and Golgi apparatus. SLC35B2 is located in the microsomal membrane and transports PAPS from the cytosol, where it is synthesized, into the Golgi lumen (Kamiyama et al., 2003 [PubMed 12716889]).[supplied by OMIM, Mar 2008]

ResearchGenerating clinical summary…
DNmechanismLOEUF 0.63
Clinical SummarySLC35B2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
3 unique Pathogenic / Likely Pathogenic· 86 VUS of 102 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.63LOEUF
pLI 0.071
Z-score 2.66
OE 0.30 (0.150.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.26Z-score
OE missense 1.05 (0.941.16)
263 obs / 251.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.30 (0.150.63)
00.351.4
Missense OE?1.05 (0.941.16)
00.61.4
Synonymous OE?1.29
01.21.6
LoF obs/exp: 5 / 16.7Missense obs/exp: 263 / 251.4Syn Z: -2.37
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSLC35B2-related chondrodysplasia with hypomyelinating leukodystrophyOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7035th %ile
GOF
0.5856th %ile
LOF
0.3261th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

102 submitted variants in ClinVar

Classification Summary

Pathogenic3
VUS86
Likely Benign5
Benign2
Conflicting1
3
Pathogenic
86
VUS
5
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
0
0
3
Likely Pathogenic
0
0
0
0
0
VUS
3
83
0
0
86
Likely Benign
0
2
0
3
5
Benign
0
1
0
1
2
Conflicting
1
Total5870497

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 11) ClinVar copy-number / structural variants overlap SLC35B2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC35B2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →